Quentis Therapeutics

Quentis Therapeutics

Quentis Therapeutics

Quentis is pioneering firstinclass endoplasmic reticulum (ER) stress responsetargeting immunotherapies to awaken the immune systems ability to fight cancer.
Type
B2c
Raised
$48M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$48,000,000
Venture capital (Series A) - 2018
Polaris Partners Versant Ventures Yonghua Capital +4
Team Size
1–10
Employees
FinSMEs

Quentis Therapeutics Raises $48M in Series A Financing